BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 11591612)

  • 1. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy.
    Rueckschloss U; Galle J; Holtz J; Zerkowski HR; Morawietz H
    Circulation; 2001 Oct; 104(15):1767-72. PubMed ID: 11591612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease.
    Rueckschloss U; Quinn MT; Holtz J; Morawietz H
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1845-51. PubMed ID: 12426214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol.
    Shin HK; Kim YK; Kim KY; Lee JH; Hong KW
    Circulation; 2004 Mar; 109(8):1022-8. PubMed ID: 14967724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II.
    Touyz RM; Chen X; Tabet F; Yao G; He G; Quinn MT; Pagano PJ; Schiffrin EL
    Circ Res; 2002 Jun; 90(11):1205-13. PubMed ID: 12065324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins.
    Guzik TJ; Sadowski J; Kapelak B; Jopek A; Rudzinski P; Pillai R; Korbut R; Channon KM
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1614-20. PubMed ID: 15256399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a functional leukocyte-type NADPH oxidase in human endothelial cells :a potential atherogenic source of reactive oxygen species.
    Meyer JW; Holland JA; Ziegler LM; Chang MM; Beebe G; Schmitt ME
    Endothelium; 1999; 7(1):11-22. PubMed ID: 10599557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superoxide production and expression of nox family proteins in human atherosclerosis.
    Sorescu D; Weiss D; Lassègue B; Clempus RE; Szöcs K; Sorescu GP; Valppu L; Quinn MT; Lambeth JD; Vega JD; Taylor WR; Griendling KK
    Circulation; 2002 Mar; 105(12):1429-35. PubMed ID: 11914250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual effect of oxidized LDL on cell cycle in human endothelial cells through oxidative stress.
    Galle J; Heinloth A; Wanner C; Heermeier K
    Kidney Int Suppl; 2001 Feb; 78():S120-3. PubMed ID: 11168996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells.
    Heinloth A; Heermeier K; Raff U; Wanner C; Galle J
    J Am Soc Nephrol; 2000 Oct; 11(10):1819-1825. PubMed ID: 11004212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis.
    Guzik TJ; West NE; Black E; McDonald D; Ratnatunga C; Pillai R; Channon KM
    Circulation; 2000 Oct; 102(15):1744-7. PubMed ID: 11023926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase.
    Guzik TJ; Mussa S; Gastaldi D; Sadowski J; Ratnatunga C; Pillai R; Channon KM
    Circulation; 2002 Apr; 105(14):1656-62. PubMed ID: 11940543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular NAD(P)H oxidase triggers delayed cerebral vasospasm after subarachnoid hemorrhage in rats.
    Kim DE; Suh YS; Lee MS; Kim KY; Lee JH; Lee HS; Hong KW; Kim CD
    Stroke; 2002 Nov; 33(11):2687-91. PubMed ID: 12411662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in primary endothelial cells.
    Inoue I; Goto S; Mizotani K; Awata T; Mastunaga T; Kawai S; Nakajima T; Hokari S; Komoda T; Katayama S
    Life Sci; 2000 Jul; 67(8):863-76. PubMed ID: 10946846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes.
    Wang S; Zhang M; Liang B; Xu J; Xie Z; Liu C; Viollet B; Yan D; Zou MH
    Circ Res; 2010 Apr; 106(6):1117-28. PubMed ID: 20167927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antioxidant properties of statins].
    Drinitsina SV; Zateĭshchikov DA
    Kardiologiia; 2005; 45(4):65-72. PubMed ID: 15940196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NO-mediated regulation of NAD(P)H oxidase by laminar shear stress in human endothelial cells.
    Duerrschmidt N; Stielow C; Muller G; Pagano PJ; Morawietz H
    J Physiol; 2006 Oct; 576(Pt 2):557-67. PubMed ID: 16873416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice.
    Vecchione C; Brandes RP
    Circ Res; 2002 Jul; 91(2):173-9. PubMed ID: 12142351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAD(P)H oxidase activity in cultured human podocytes: effects of adenosine triphosphate.
    Greiber S; Münzel T; Kästner S; Müller B; Schollmeyer P; Pavenstädt H
    Kidney Int; 1998 Mar; 53(3):654-63. PubMed ID: 9507211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thioredoxin attenuates oxidized low-density lipoprotein induced oxidative stress in human umbilical vein endothelial cells by reducing NADPH oxidase activity.
    Chen B; Meng L; Shen T; Gong H; Qi R; Zhao Y; Sun J; Bao L; Zhao G
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1326-1333. PubMed ID: 28688762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD(P)H oxidase participates in the signaling events in high glucose-induced proliferation of vascular smooth muscle cells.
    Lee HS; Son SM; Kim YK; Hong KW; Kim CD
    Life Sci; 2003 May; 72(24):2719-30. PubMed ID: 12679189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.